Delivery Order SPE2DB24D1201-SPE2DB25FJCHG

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $37,356.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,236,569 units of the prescription medication Jardiance 25 mg tablets. The delivery order has a period of performance through May 14, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $12,576.24 contract is for the supply of 4,567,476,127 units of Jardiance 10 mg tablets. The contract has a period of performance through March 6, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,062.29, is for the supply of 4,568,175,266 units of the prescription medication Jardiance 25 mg tablets. The contract has an ultimate completion date of May 8, 2025. AmerisourceBergen Drug Corp is a for-profit organization and a registered vendor in SAM.gov. The company holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,306.49, is for the delivery of 4,568,011,624 units of the prescription medication Jardiance 25 mg tablets. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program and represents an open competition....
This is a $23,417.38 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 90-count tablets of the prescription drug Jardiance 25 mg. The contract has a period of performance through May 19, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,494.05 contract is for the supply of 4,567,951,867 units of the diabetes medication Jardiance 25 mg tablets. The award has an ultimate completion date of April 18, 2025 and was made on April 17, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,906.81, is for the delivery of 4,567,957,203 units of the diabetes medication Jardiance 25 mg tablet with a completion date of April 18, 2025. This contract is not designated as a set-aside and is considered an open competition. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,996,072 units of the diabetes medication Jardiance 25 mg tablets. The contract has a ceiling value of $25,342.73 and a period of performance through April 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,868.52, is for the provision of Jardiance 25 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,876.74, is for the delivery of 4,567,957,360 units of the diabetes medication Jardiance 25 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJCHG
    Delivery Order

This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,737.60, is for the supply of 4,567,957,244 units of the prescription medication Jardiance 25 mg tablets. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 2:38 PM